It is not often that an entirely new, effective, class of therapy is discovered, especially in a disease as difficult to treat as cancer. It is even less common that a completely new therapeutic is effective in a large majority of patients right from the start. But chimeric antigen receptor T cell therapy?CAR T-cell therapy? is anything but typical

Els van der Heijden, who has cystic fibrosis, was finding it ever harder to breathe as her lungs filled with thick, sticky mucus. Despite taking more than a dozen pills and inhalers a day, the 53-year-old had to stop working and scale back doing the thing she loved best, horseback riding...

Referring to Article 144 of the Constitution, the president of Iran assigned ?Sorena Sattari? as the ?vice president for science and technology affairs? in a verdict.

Last week, two people with type 1 diabetes became the first to receive implants containing cells generated from embryonic stem cells to treat their condition. The hope is that when blood sugar levels rise, the implants will release insulin to restore them to normal.

According to the news headquarter of the second national festival and international congress of stem cells and regenerative medicine, Amir Ali Hamidieh, secretary of stem cells science and technology development headquarter, expressed the warm welcome of the festival at the closing ceremony of the event, stating: given the warm welcome by the participants, registration for the event ended two weeks after announcing the call due to the great number of referrals. In total, three thousand individuals participated in the second round of this festival.

Cancer cells, like stem cells, have the ability to multiply indefinitely; epigenetic factor BPTF may be a shared weakness

The term organoid first gained use in the mid-1960?s to describe cell aggregates observed during dissociation and re-aggregation experiments in classic developmental biology. Today, the term organoid refers to three-dimensional structures containing multiple organotypic cell types, recapitulating some of

Researchers from the Japanese RIKEN Centre have reportedly delivered induced pluripotent stem (iPS) cells from an anonymous donor to a 60 year old male patient. The milestone is understood to represent a world first in the development of stem cell technology, in addition to changing the medical approach to how such treatments may become more widely available than first anticipated. Previous protocols have focused on the delivery of a patient?s own cells using a very different clinical procedure to that which may be envisioned from using a ?democratized? cell bank.

According to council public relations and international affairs, the second national festival and international congress on stem cell and regenerative medicine will be held on 13-15 July 2017 in I.R.Iran international conference center ( Saran conference hall ).

A few weeks ago, we reported on the creation of microengineered particle-based cardiac tissue function by functionalizing PLGA microparticles with cardiac cell-extracted growth factors.